MyAverix Finance
US · Healthcare
Dynavax Technologies Corporation (DVAX)
Drug Manufacturers - Specialty & Generic
Dynavax Technologies Corporation (DVAX) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for DVAX
Dynavax Technologies Corporation (DVAX) — FAQ
What is DVAX's P/E ratio?
The price-to-earnings (P/E) ratio for Dynavax Technologies Corporation (DVAX) is 18.00 (data as of 2026-03-24).
Does Dynavax Technologies Corporation pay a dividend?
Dividend yield is not available in the current snapshot for Dynavax Technologies Corporation (DVAX). Check the MyAverix Finance app for the latest dividend data.
What sector is Dynavax Technologies Corporation in?
Dynavax Technologies Corporation (DVAX) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is DVAX listed on?
DVAX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.